Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002045942 | SCV002302782 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 4 | 2023-05-21 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1513561). This variant has not been reported in the literature in individuals affected with RAD51D-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 16 of the RAD51D protein (p.Met16Leu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. |
Baylor Genetics | RCV002045942 | SCV004200420 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 4 | 2023-05-12 | criteria provided, single submitter | clinical testing |